Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spok HoldingsSPOK +1.95%58 EV-to-EBIT is 12.48 as of Aug. 08, 2026, which is 7% below its 10-year median of 13.39. GuruFocus rates SPOK with a GF Score™ of 58/100 and a GF Value™ of $14.55 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Spok Holdings ranks better than 64.12% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Spok Holdings's Enterprise Value for the quarter that ended in Jun. 2026 was $203.2 Mil.
Spok Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spok Holdings EV-to-EBIT Related Terms
Spok Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Spok Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Spok Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spok Holdings EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spok Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Spok Holdings's EV-to-EBIT falls into.
Spok Holdings's current Enterprise Value is $229.9 Mil.
Spok Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spok Holdings (SPOK) has a EV-to-EBIT of 12.48 as of Aug. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Spok Holdings and its competitors. This is near median its historical median of 13.39. According to the industry distribution chart, Spok Holdings ranks #169 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 35.9%.
Is Spok Holdings' EV-to-EBIT too high?
Spok Holdings' current EV-to-EBIT of 12.48 is near median its 10-year median of 13.39. The Healthcare Providers & Services industry median EV-to-EBIT is 16.04. Spok Holdings' value of 12.48 is 22.2% below this industry median. Based on the distribution chart, Spok Holdings ranks #169 out of 471 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Spok Holdings has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spok Holdings' EV-to-EBIT compare to SY and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Spok Holdings ranks #169 out of 471 companies for EV-to-EBIT. This puts Spok Holdings in the upper half of its industry. The industry median EV-to-EBIT is 16.04. Spok Holdings' value of 12.48 is 22.2% below this benchmark. While the company's 10-year median is 13.39 vs. the industry median of 16.04, Spok Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 16.04, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spok Holdings's current EV-to-EBIT of 12.48 is 22.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Spok Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 16.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spok Holdings's current EV-to-EBIT is 12.48, which is near median its own 10-year median of 13.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spok Holdings stock overvalued right now?
Based on GuruFocus' analysis, Spok Holdings (SPOK) is currently considered Modestly Undervalued. The stock's GF Value™ is $14.55, compared to a current price of $11.51 — trading 20.9% below its estimated fair value. The current EV-to-EBIT is 12.48, which is near median its 10-year median of 13.39 and 22.2% below the Healthcare Providers & Services industry median of 16.04. Spok Holdings' overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Spok Holdings (SPOK), the current EV-to-EBIT is 12.48 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spok Holdings (SPOK) Overvalued in 2026?
Based on GuruFocus' analysis, Spok Holdings stock appears to be undervalued.
The current stock price of $11.51 is trading 20.9% below its estimated GF Value™ of $14.55.
GuruFocus considers Spok Holdings to be Modestly Undervalued.
Key valuation signals for SPOK:
EV-to-EBIT: 12.48 (near median its 10-year median of 13.39)
GF Value™: $14.55 vs. price of $11.51 (20.9% below fair value)
Industry Position: 22.2% below the Healthcare Providers & Services median (#169 of 471)
No single metric tells the full story. See the SPOK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
58GF Score
Get the complete analysis for SPOK
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SPOK has been successfully added to your 
